Navigation Links
Bioheart Reports Significant Improvements in Heart Failure Patients from Center of Excellence Program
Date:8/26/2010

SUNRISE, Fla., Aug. 26 /PRNewswire-FirstCall/ -- Bioheart, Inc., (OTC Bulletin Board: BHRT) announces that the treatments and 3 month follow up with stem cell therapy on the first two congestive heart failure patients has been performed successfully at Hospital Angeles Tijuana through its Center of Excellence, Regenerative Medicine Institute of Tijuana, Mexico. In March, Bioheart entered into an agreement to establish a Center of Excellence for the introduction of its therapies. Through the program with Bioheart, Regenerative Medicine Institute provides therapies for congestive heart failure (CHF) and peripheral arterial disease (PAD) patients at the Hospital Angeles Tijuana, a fully equipped state-of–the-art private specialties hospital.

The therapy involved the use of stem cells derived from the patient's own fat (adipose tissue) obtained using liposuction. Stem cells were separated from the adipose tissue utilizing the fully-automated TGI Cell Isolation System. The separation process takes about an hour. No tissue pre-processing is required with this system. The recovered stem cells were injected into the patients' hearts with Bioheart's MyoCath® needle injection catheter.

Dr. Juan J. Parcero, the treating Interventional Cardiologist and head of the cardiac program at the Hospital Angeles commented on Bioheart's program, "The ability to offer cutting edge treatments and regenerative medicine has provided new hope to these patients. We are very pleased with the positive outcomes seen in the patients treated so far." Dr. Parcero has led the efforts with this new program with expert team members Drs. Oscar Mendoza and Luis Ruvalcaba, Echo cardiologists, Dr. Silvia Gonzalez, Plastic Surgeon, Dr. Nelson Varas, Anesthesiologist Cardiologist and Dr. Jesus Perez, Hospitalist.

To date, four patients have been treated utilizing the TGI Cell Isolation Syst
'/>"/>

SOURCE Bioheart, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Bioheart, Inc. Announces Additional Funding Support
2. United States FDA Clears the REGEN Trial to Test Biohearts Combination Gene and Stem Cell Therapy in Heart Failure Patients
3. Bioheart Strengthens Executive Team in Order to Accelerate Business Plan and Enhance Its Position in the Cardiovascular Stem Cell Therapy Industry
4. Bioheart Inc. to Participate in the 2009 World Stem Cell Summit on September 23rd
5. Bioheart Makes Breakthrough in Critical Limb Ischemia Therapy with Stem Cells Obtained from Fat Tissue
6. SCOLR Pharma, Inc. Reports Second Quarter 2008 Financial Results
7. AutoImmune Inc. Reports 2008 Second Quarter Financial Results
8. Par Pharmaceutical Reports Second Quarter 2008 Results
9. ISTA Pharmaceuticals Reports Second Quarter 2008 Financial Results
10. Pharmos Corporation Reports 2008 Second Quarter Results
11. Halozyme Therapeutics Reports 2008 Second Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)...  United Therapeutics Corporation (NASDAQ: UTHR ) ... changes to Martine Rothblatt , Ph.D,s compensation program. ... United Therapeutics announced the promotion of Roger Jeffs ... David Zaccardelli , Pharm.D. to Executive Vice President ... Dr. Rothblatt,s title will change from Chairman and Chief ...
(Date:12/15/2014)... NEW YORK & PETACH TIKVAH, ... Therapeutics Inc. (NASDAQ: BCLI ), a leading ... announced today that wholly-owned subsidiary Brainstorm Cell Therapeutics Ltd. ... Israel,s Office of the Chief ... has been in receipt of grant support from the ...
(Date:12/13/2014)... CanDiag, Inc., a University of North Carolina at ... to OncoTab, Inc. , “The new name is ... said CEO and Chief Science Officer, Dr. Pinku Mukherjee, ... diagnostics to include imaging and therapies, and our new ... in 2011 by Dr. Mukherjee, an Irwin Belk Endowed ...
(Date:12/13/2014)... (PRWEB) December 13, 2014 The ... the major market drivers, threats, opportunities, and challenges. ... by three major players, namely, Thermo Fisher Scientific, ... (Netherlands). These players jointly accounted for approximately ~65% ... , Full Copy for This Report @ ...
Breaking Biology Technology:United Therapeutics Corporation Announces Executive Promotions and CEO Compensation Change 2United Therapeutics Corporation Announces Executive Promotions and CEO Compensation Change 3United Therapeutics Corporation Announces Executive Promotions and CEO Compensation Change 4BrainStorm Receives $1,100,000 for its 8th Annual Non-Dilutive Grant from Israel's Chief Scientist Office 2BrainStorm Receives $1,100,000 for its 8th Annual Non-Dilutive Grant from Israel's Chief Scientist Office 3CanDiag Inc. Expands Product Scope Under a New Name: OncoTab, Inc. 2Synthetic Biology Market to HIt $5.6304 Billion by 2018 - New Research Report by MarketsandMakets 2Synthetic Biology Market to HIt $5.6304 Billion by 2018 - New Research Report by MarketsandMakets 3
... , WHITE PLAINS, N.Y., Dec. 24 Bunge Limited ("Bunge") (NYSE: ... an agreement to become the 100% owner of Usina Moema Participacoes ... wholly owns one sugarcane mill in Brazil and has ownership interests ... Group") has an annual crushing capacity of 15.4 million metric tons. ...
... , , , , , , SAN ... ARNA ) announced today Merck and Co., Inc.,s decision (through ... receptor agonist to treat atherosclerosis being developed under its research ... will not continue the collaboration. , Merck made the decision ...
... , , , , SHANGHAI, Dec. ... a,leading pharmaceutical, biotechnology, and medical-device research and,development outsourcing company with ... of its third Life Science and Chemistry Awards,held on December ... (Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO ) , ...
Cached Biology Technology:Bunge Limited to Expand Sugar and Bioenergy Business in Brazil 2Bunge Limited to Expand Sugar and Bioenergy Business in Brazil 3Bunge Limited to Expand Sugar and Bioenergy Business in Brazil 4Bunge Limited to Expand Sugar and Bioenergy Business in Brazil 5Arena Pharmaceuticals Announces Merck Discontinues Development of Investigational Niacin Receptor Agonist Program for Atherosclerosis 2Arena Pharmaceuticals Announces Merck Discontinues Development of Investigational Niacin Receptor Agonist Program for Atherosclerosis 3WuXi PharmaTech (NYSE: WX) Holds Its Third Life Science and Chemistry Awards Ceremony in Beijing 2WuXi PharmaTech (NYSE: WX) Holds Its Third Life Science and Chemistry Awards Ceremony in Beijing 3WuXi PharmaTech (NYSE: WX) Holds Its Third Life Science and Chemistry Awards Ceremony in Beijing 4
(Date:12/17/2014)... 2014  HITLAB SM announced today its ... to confirm its adherence to current U.S. Food ... HITLAB to conduct regulated smart device and smart ... patient safety and research quality. "HITLAB ... and delivery with innovative technology," said Laura ...
(Date:12/17/2014)... Research and Markets ( http://www.researchandmarkets.com/research/9zq33j/global_chemical ... "Global Chemical Sensor Market 2015-2019" report to ... One major trend upcoming in ... sensors in biomedical applications. Chemical sensors help in ... diagnosis during surgical procedures. The Global Chemical Sensor ...
(Date:12/15/2014)... Research and Markets ( http://www.researchandmarkets.com/research/87pph8/global_facial ... "Global Facial Recognition Market 2015-2019" report to ... Facial recognition is a technology ... system measures the overall facial feature of a ... the distance between eyes. Facial recognition is used ...
Breaking Biology News(10 mins):HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3
... more irritating than a fly buzzing around the house. South ... up a bunch of Roridula gorgonias leaves. Attracted ... hapless pest is soon trapped by the natural flypaper. However, ... gorgonias plant is home to a population of Pameridea ...
... the grade with the,introduction of the stylish Cyber-shot(R) DSC-T700 ... 10-megapixel T77 camera is Sony,s thinnest model at less ... 9 touch panel LCD screen. It features,updated intelligent scene ... and adult priority, as well as high,sensitivity shooting (up ...
... of Georgia researchers were recently awarded two grants totaling ... biofuels from switchgrass and sunflowers. UGA was one ... jointly funded by the U.S. Department of Agriculture and ... accelerate research in biomass genomics and further the use ...
Cached Biology News:How non-stick bugs evade natural fly paper 2Sony Cyber-shot Cameras Get Smarter 2Sony Cyber-shot Cameras Get Smarter 3UGA gets $2.5 million in grants to study plants to make biofuels 2UGA gets $2.5 million in grants to study plants to make biofuels 3
... The Zero Blunt ... offers the fastest and ... (greater than or equal ... PCR products amplified with ...
Blot Paper 7 x 8.5cm semi-dry western blots (order number RB-400)...
... Create 100% capped transcripts with the ... higher yields of 100% capped (versus 40% ... mRNA messages in about 2 hours. mScript™ ... has been shown to be up to ...
Immunogen: Synthetic peptide: M(1) C V P R S G L I L S(11) Storage: -20 C, Avoid Freeze/Thaw Cycles...
Biology Products: